What stem cells have to do with stomach cancer
The surface of the stomach is lined by a delicate single-layered sheet of epithelial cells (termed the gastric mucosa and its glands), which represents a tight barrier to the outside world (i.e., the gastric juice and its contents including a variety of microorganisms, such as Helicobacter pylori) and is also essential for the digestion of food. The stomach consists of two major parts (Fig. 1), a proximal fundus/corpus region with fundic glands producing the gastric acid, and the distal antrum with antral glands releasing the peptide hormone gastrin. During evolution, a series of protection and repair mechanisms have been developed because the gastric mucosa is permanently exposed to different noxious agents. These mechanisms include the formation of a complex mucous gel containing mucins, secretion of antimicrobial peptides, acute inflammatory processes, rapid repair by cell migration (restitution) within minutes to hours, and continual self-renewal of the various cell types by differentiation from progenitor cells and adult (somatic) stem cells (Fig. 1). The latter process takes days to months depending on the cell type.
Only within the last few years it has become clear that gastric glands contain an unexpected variety of stem cell populations, which are even different in fundic and antral glands (Fig. 1). Of note, the isthmus is no longer thought to serve as the exclusive stem cell reservoir. Thus far, the relation and the hierarchy, respectively, between the different gastric stem cell (GSC) populations in a single gastric unit have not been established.
Some 90% of primary tumors in adult humans arise from epithelia mainly on the base of chronic inflammation because of their high regenerative capacity and the existence of adult stem cells. Gastric cancer is still a leading cause of cancer-related mortality worldwide (10% of total cancer deaths in 2008) in spite of declining incidence. Gastric cancers are essentially adenocarcinomas (90%) and 50% of these epithelial tumors are classified histologically as the “intestinal” type. Gastric cancer is promoted by environmental factors such as smoked meat, chilli peppers, alcohol, and smoking. However, the most striking risk factor is infection with H. pylori causing chronic inflammation (gastritis). For the intestinal type of adenocarcinomas, a well-defined sequence of events (the “Correa cascade”) has been known for a long time, starting from chronic gastritis and proceeding to gastric atrophy (loss of parietal and zymogenic cells), intestinal metaplasia (aberrant occurrence of intestinal cells in the stomach), and dysplasia. Within the last years it turned out that also a second type of metaplasia (the “spasmolytic polypeptide-expressing metaplasia”/SPEM) is involved in gastric carcinogenesis.
Tumors consist of a heterogeneous, hierarchical population of cancer cells. Importantly, only cancer stem cells (CSCs) can initiate tumor formation. Thus, CSC-targeted therapies might be promising future strategies to cure gastric cancer. Currently, there are three origins of gastric CSCs discussed, i.e., (i) dedifferentiation of metaplasias, (ii) transformation of normal adult GSCs, and (iii), to a lesser extent, engraftment of bone marrow-derived mesenchymal stem cells under the conditions of chronic inflammation. Thus, gastric cancer is now regarded as a disease resulting from the dysregulated differentiation of certain stem and progenitor cells mainly due to a chronic inflammatory environment. Understanding the self-renewal of the gastric mucosa is an important contribution in understanding gastric carcinogenesis and in developing new gastric cancer therapies.
Institute of Molecular Biology and Medicinal Chemistry,
Otto-von-Guericke-University Magdeburg, Germany
Current Status on Stem Cells and Cancers of the Gastric Epithelium.
Int J Mol Sci. 2015 Aug
|The choroid plexus: a new player in the… The healthy human gut microbiome contains 100 trillion bacteria, outnumbering the amount of human cells by a factor of 10. These bacteria are important in several crucial processes in our…|
|Stem cells and stem cells conditioned medium for… Inflammatory bowel disease (IBD) is a complex of pathological processes occurring in the intestine. Chemically induced IBD in rodent usually used for study of drug therapy efficacy. Mesenchymal stem cells…|
|Shedding new light on the causes and treatment of… Across the world, about one in six people suffer from chronic stomach symptoms, including feeling very full and uncomfortable or bloated after eating, being unable to finish a normal sized…|
|FTIR spectroscopy and ımaging to understand donor… Stem cells, like Bone Marrow Mesenchymal Stem Cells (MSCs), have enormous potential to develop new therapies for tissue regeneration and repair with their ability to differentiate into many different types…|
|The immunomodulatory enzyme IDO: Expression in the… IDO modulates immune responses. The enzyme indoleamine 2,3-dioxygenase 1 (IDO) degrades tryptophan. This amino acid is required for immune defences against pathogens, but also stimulates pathogen growth. Its degradation inhibits…|
|Preventing over-treatment in euthyroid patients with… Up to 12% of the U.S. population will be diagnosed with a thyroid condition. Because thyroid hormones affect every cell in the body, hypo- (low) and hyper-(high) thyroidism can be…|